David de Vries, the co-founder and Chief Executive Officer of Tr1X, is leading the company in developing innovative therapies for autoimmune and in...
Researchers have discovered a method to significantly boost the cancer-fighting capabilities of T cells, a crucial component of the immune system. ...
Amylyx Pharmaceuticals, Inc., a company focused on developing treatments for neurodegenerative and endocrine diseases, has announced its participat...
Ben Stone has been promoted to Chief Business Officer (CBO) at AnaptysBio, a clinical-stage biotechnology company focused on immunology therapeutic...
Ben Stone has been promoted to Chief Business Officer (CBO) at AnaptysBio, a clinical-stage biotechnology company. Stone, who joined AnaptysBio as ...
The Allen Institute, based in Seattle, has provided stem cells for a groundbreaking research initiative aboard the International Space Station (ISS...
Researchers at Baylor College of Medicine, in collaboration with international scientists, have discovered a brain pathway that plays a crucial rol...
A recent study has unveiled a dual-targeting strategy that effectively inhibits a range of emerging MERS-related coronaviruses (MERSr-CoVs). The re...
Charles River Laboratories International, Inc. has joined the EASYGEN Consortium, a European Union-backed initiative aimed at revolutionizing CAR-T...
Recent research has identified several MERS-related coronaviruses (MERSr-CoVs) that exhibit significant alterations in their spike proteins, allowi...